Facebook
Instagram
Linkedin
Pinterest
Twitter
Youtube
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Tag: Allergenis
Food Allergy Diagnostic Company Announces Crowdfunding Campaign You Can Invest In
Dave Bloom
-
2023/04/25
Allergenis announces public
New Blood Test Accurately Determines the Threshold Dose for Reactions to...
News Wire ~ 3rd Party Press Release
-
2022/09/15
Allergenis’ bead-based epitope assay is a breakthrough diagnostic for peanut allergy.
The Future of Food Allergy Diagnosis (Sponsored)
Allergenis
-
2022/02/17
A new product by Allergenis is set to be released in 2022 that can fill the gap left by current food allergy tests.
Making the Impossible, Possible: Redefining How Peanut Allergies are Diagnosed (Sponsored)
Allergenis
-
2022/01/11
Never before has a blood test been able to help you make the decisions you face every single day living with food allergies.
AllerGenis Lauds Study Results of New, More Accurate Blood Test for...
News Wire ~ 3rd Party Press Release
-
2021/06/15
"Test brings us one step closer to eliminating the need to subject patients to an oral food challenge."
AllerGenis Begins Testing Patient Samples for Peanut Allergy Using Proprietary Epitope...
News Wire ~ 3rd Party Press Release
-
2020/06/24
VeriMAP Peanut Diagnostic has a 93% concordance with food challenge results providing a diagnosis with greater certainty.
Test is 87% Accurate at Determining Outcome to Milk OIT
News Wire ~ 3rd Party Press Release
-
2018/12/20
Using a growing database of patient reactivity signatures can better predict milk-allergic patient outcomes compared to traditional methods.
Mount Sinai and AllerGenis Announce Partnership to Bring Novel, Precision Diagnostics...
News Wire ~ 3rd Party Press Release
-
2018/11/06
The technology will provide an improved method for detecting, assessing, and monitoring food allergies in patients.